`U.S. SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                   FORM 10-QSB

[ X ]  QUARTERLY  REPORT  PURSUANT  TO  SECTION  13 OR 15(d)  OF THE  SECURITIES
EXCHANGE ACT OF 1934

      For the quarterly period ended September 30, 2003

[ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE
ACT OF 1934

      For the transition period from     to

                          Commission File No. 333-85460

                          Vibrant Health International
        (Exact name of small business issuer as specified in its charter)

                 Nevada                                84-1595734
    (State or other jurisdiction of         (IRS Employer Identification No.)
     incorporation or organization)

               8907 E. Chenango Ave, Greenwood Village, CO, 80111
                    (Address of principal executive offices)

                                  303-713-1870
                           (Issuer's telephone number)

                                 Not Applicable
   (Former name, former address and fiscal year if changed since last report)

Check  whether  the issuer  (1) has filed all  reports  required  to be filed by
Section 13 or 15(d) of the Exchange  Act during the  preceding 12 months (or for
such shorter period that the issuer was required to file such reports),  and (2)
has been subject to such filing requirements for the past 90 days. Yes [ X] No [
]

As of  September  30, 2003,  the issuer had  4,360,600  shares of common  stock,
$0.001 par value issued and outstanding.

Transitional Small Business Format:  Yes [   ]  No [ X ]



                                   FORM 10-QSB
                          VIBRANT HEALTH INTERNATIONAL
                          (A Development Stage Company)
                                      INDEX


PART I.    Financial Information

           Item 1.  Consolidated Financial Statements

           Consolidated Balance Sheet as of September 30, 2003
           (unaudited) and December 31, 2002

           Unaudited Consolidated Statements of Operations for the
           Three and Nine Months ended September, 2003 and 2002 and the
           period from December 3, 1997 (inception) through September 30, 2003

           Unaudited Consolidated Statement of Stockholders' Equity for
           the period from December 3, 1997 (inception) through
           September 30, 2003

           Unaudited Consolidated Statements of Cash Flows for the Nine
           Months ended September 30, 2003 and 2002 and the period from
           December 3, 1997 (inception) through September 30, 2003

           Notes to Unaudited Consolidated Financial Statements

           Item 2.  Management's Discussion and Analysis or Plan of Operation

           Item 3.  Controls and Procedures

PART II.   Other Information

           Item 1.  Legal Proceedings

           Item 2.  Changes in Securities and Use of Proceeds

           Item 6.  Exhibits and Reports on Form 8-K

           Signatures

(Inapplicable items have been omitted)


PART I.

Financial Information

Item 1.  Consolidated Financial Statements (unaudited)

In the opinion of management,  the accompanying unaudited consolidated financial
statements included in this Form 10-QSB reflect all adjustments (consisting only
of normal recurring  accruals)  necessary for a fair presentation of the results
of  operations  for the periods  presented.  The results of  operations  for the
periods  presented are not necessarily  indicative of the results to be expected
for the full year.




          VIBRANT HEALTH INTERNATIONAL AND ITS WHOLLY OWNED SUBSIDIARY
                          (a Development Stage Company)

                           Consolidated Balance Sheet


                                                           September 30,     December 31,
                                                               2003             2002
                                                            ------------    ------------
                                                            (unaudited)
                                         Assets

Current assets
  Cash                                                      $     23,307    $     49,028
                                                            ------------    ------------

Total assets                                                $     23,307    $     49,028
                                                            ============    ============

                          Liabilities and Stockholders' Equity

Current liabilities
  Accounts payable and accrued expenses                     $      4,052    $      1,891
                                                            ------------    ------------
   Total current liabilities                                       4,052           1,891
                                                            ------------    ------------

Commitments and contingencies

Stockholders' equity
  Common stock, authorized 100,000,000 shares, $.001
   par value; 4,360,600 shares issued and outstanding              4,361           4,361
  Additional paid-in capital                                     110,009         110,009
  Deficit accumulated during the development stage               (95,115)        (67,233)
                                                            ------------    ------------
   Total stockholders' equity                                     19,255          47,137
                                                            ------------    ------------

Total liabilities and stockholders' equity                  $     23,307    $     49,028
                                                            ============    ============




                 Unaudited Consolidated Statements of Operations


                                                                                 For the
                                                                                 Period
                                                                                  from
                                                                                December
                            For the Three Months       For the Nine Months       3, 1997
                                    Ended                     Ended            (Inception)
                           ------------------------   -----------------------    through
                           September     September    September    September   September 30,
                            30, 2003     30, 2002     30, 2003     30, 2002       2003
                           ----------    ----------   ----------   ----------   ----------
                          (unaudited)   (unaudited)  (unaudited)  (unaudited)  (unaudited)

Sales                      $    6,800    $   15,791   $   19,794   $   19,604   $   47,953

Cost of goods sold              1,933         5,215        5,791        6,575       15,472
                           ----------    ----------   ----------   ----------   ----------

Gross profit                    4,867        10,576       14,003       13,029       32,481
                           ----------    ----------   ----------   ----------   ----------

Operating expenses
    Website development
   costs                           -             -    -       -         2,209       13,844
    General and
   administrative
   expenses                    10,143        20,762       42,132       38,903      109,340
                           ----------    ----------   ----------   ----------   ----------
       Total operating
expenses                       10,143        20,762       42,132       41,112      123,184
                           ----------    ----------   ----------   ----------   ----------

Loss from operations           (5,276)      (10,186)     (28,129)     (28,083)     (90,703)

Interest expense                   -           (842)          -        (3,642)      (4,747)
Interest income                    54            -           247           -           335
                           ----------    ----------   ----------   ----------   ----------

Net loss                   $   (5,222)   $  (11,028)  $  (27,882)  $  (31,725)  $  (95,115)
                           ==========    ==========   ==========   ==========   ==========

Earnings (loss) per
 share - basic and
 diluted                   $   (0.001)   $   (0.002)  $   (0.006)  $   (0.008)
                           ==========    ==========   ==========   ==========

Weighted average shares
 outstanding                4,360,600     3,935,000    4,360,600    3,935,000
                           ==========    ==========   ==========   ==========




            Unaudited Consolidated Statement of Stockholders' Equity
   For the Period from December 3, 1997 (Inception) through September 30, 2003


                                                                Deficit
                                                              Accumulated
                               Common Stock       Additional   During the      Total
                           ---------------------   Paid-In    Development   Stockholders'
                            Shares      Amount     Capital       Stage        Equity
                           ---------   ---------   ---------   ----------    ----------
Balance - December 3,
 1997 (Inception)                 -    $      -    $      -    $       -     $       -

Stock issued                 970,000         970          -            -            970

Net loss for periods              -           -           -          (897)         (897)
                           ---------   ---------   ---------   ----------    ----------

Balance - December 31,
 2000                        970,000         970          -          (897)           73

Stock issued               2,965,000       2,965       4,035           -          7,000

Net loss                          -           -           -       (25,128)      (25,128)
                           ---------   ---------   ---------   ----------    ----------

Balance - December 31,
 2001                      3,935,000       3,935       4,035      (26,025)      (18,055)

Stock issued                 425,600         426     105,974           -        106,400

Net loss                          -           -           -       (41,208)      (41,208)
                           ---------   ---------   ---------   ----------    ----------

Balance - December 31,
 2002                      4,360,600       4,361     110,009      (67,233)       47,137

Net loss                          -           -           -       (27,882)      (27,882)
                           ---------   ---------   ---------   ----------    ----------

Balance - September 30,
 2003                      4,360,600   $   4,361   $ 110,009   $  (95,115)   $   19,255
                           =========   =========   =========   ==========    ==========




                 Unaudited Consolidated Statements of Cash Flows


                                                                               For the
                                                                             Period from
                                                                             December 3,
                                                                                 1997
                                               For the Nine Months Ended     (Inception)
                                              ----------------------------     through
                                              September 30,  September 30,   September 30,
                                                  2003           2002            2003
                                              ------------   -------------   -------------
                                              (unaudited)    (unaudited)     (unaudited)
Cash flows from operating activities
  Net loss                                    $    (27,882)  $     (31,725)  $     (95,115)
  Adjustments  to reconcile net loss to net
  cash used in operating activities
   Common stock issued for interest expense             -               -              750
   Changes   in   operating    assets   and
    liabilities accounts receivable                     -            (362)              -
     Accounts payable and accrued expenses           2,161          16,598           4,052
                                              ------------   -------------   -------------
      Net cash used in operating activities        (25,721)        (15,489)        (90,313)
                                              ------------   -------------   -------------

Cash flows from financing activities
  Proceeds from issuance of common stock                -               -          113,620
                                              ------------   -------------   -------------
      Net cash provided by financing
       activities                                       -               -          113,620
                                              ------------   -------------   -------------

Net (decrease) increase in cash                    (25,721)        (15,489)         23,307

Cash, beginning of period                           49,028          23,009               -
                                              ------------   -------------   -------------

Cash, end of period                           $     23,307   $       7,520   $      23,307
                                              ============   =============   =============




              Notes to Unaudited Consolidated Financial Statements


Note 1 - Organization and Summary of Significant Accounting Policies

Vibrant  Health  International  (the  Company),  was formed on July 9, 2001 as a
Nevada company.  The Company's  business  operations and contracts are primarily
conducted by its wholly owned subsidiary, Vibrant Health, Inc.

Vibrant  Health,  Inc.  was formed on  December  3, 1997 as a Colorado  company.
Vibrant  Health,  Inc. is a supplier and  distributor of health and  nutritional
products via use of the Internet. Operations since inception consist principally
of setting up the Company,  developing the Company's websites,  and commencement
of initial product sales.

On July 9, 2001, the Company issued 2,910,000 shares of common stock in exchange
for 100% of the  outstanding  shares of Vibrant  Health,  Inc. due to the common
ownership  of  the   companies,   the   acquisition   was  accounted  for  as  a
recapitalization of Vibrant Health, Inc.


Note 2 - Liquidity and Management's Plans

The Company has incurred  accumulated  losses of approximately  $95,000 from the
inception of Vibrant  Health  International  through  September 30, 2003.  These
losses and the significant  future cash  requirements  related to developing the
business indicate  substantial doubt that the Company may be able to continue as
a going  concern  unless  additional  capital is obtained  or future  profitable
operations are achieved.

During 2002, the Company completed a Form SB-2 Registration  Statement under the
Securities  Act of 1933.  The  offering  was  closed in  October  2002 and total
proceeds of $106,400 were released to the Company from escrow. In the opinion of
management,  with the resources currently available, the Company will be able to
maintain its operations through September 30, 2004.



Item 2. Management's Discussion and Analysis or Plan of Operation

FORWARD-LOOKING STATEMENTS

This  Quarterly  Report  on Form  10-QSB  contains  forward-looking  statements.
Additional written or oral forward-looking statements may be made by the Company
from time to time in filings  with the  Securities  and Exchange  Commission  or
otherwise.  The words  "believe,"  "expect,"  "seek," and  "intend"  and similar
expressions identify forward-looking statements, which speak only as of the date
the statement is made. Such forward-looking statements are within the meaning of
that term in Section 27A of the Securities Act of 1933, as amended,  and Section
21E of the  Securities  Exchange Act of 1934, as amended.  Such  statements  may
include,  but are not limited to,  projections of income or loss,  expenditures,
acquisitions,  plans for future operations, financing needs or plans relating to
services of the  Company,  as well as  assumptions  relating  to the  foregoing.
Forward-looking  statements are inherently  subject to risks and  uncertainties,
some of which  cannot be  predicted  or  quantified.  Future  events  and actual
results  could differ  materially  from those set forth in,  contemplated  by or
underlying the forward-looking statements.

The Company does not undertake,  and specifically  disclaims,  any obligation to
publicly release the results of revisions,  which may be made to forward-looking
statements to reflect the occurrence of anticipated or  unanticipated  events or
circumstances after such statements.

General

We were  incorporated  in Nevada on July 9, 2001. We are a distributor of health
and nutritional  products.  We have commenced only limited  operations as of the
date of this filing.  Currently,  we are distributing healthcare products to our
customers     via    orders     generated    on    our    Internet     websites,
www.vibranthealthonline.com and www.yahoovibranthealth.com. Our current business
operations and related  operational  contracts are being conducted by our wholly
owned subsidiary, Vibrant Health, Inc., a Colorado corporation.

Our Business

We distribute  health and nutritional  products.  We are a distribution  company
only and do not have any expertise in nutritional science or manufacturing.  The
name Vibrant  Health does not reflect  health  expertise but rather is marketing
oriented,  and was  selected  to  instill in our  customers  a feeling of vigor,
energy,  and  motivation,  with the clarifying  word of health  pinpointing  our
product focus.  We believe that  individuals  with such feelings will understand
the value of fitness and appreciate the value of our products.

We are focusing our initial marketing efforts in generating sales orders through
our  Internet  websites.  Our  websites  are   www.vibranthealthonline.com   and
www.yahoovibranthealth.com.  We will  accept  ancillary  orders  when  they  are
available  to us by  facsimile,  email,  phone  calls,  or  mail.  However,  our
promotional  materials  generally  advocate and guide the potential  customer to
route  orders  for  our  product  via  our  websites.  Our  websites  are  fully
operational, however, we intend to continuously update and refine our websites.

We do not  manufacture  the products  that we sell.  Instead,  we contract  with
health and nutritional product formulators who specialize in supplying products.
Our plan, as order volume increases, will be to out-source our order fulfillment
operations so that we can focus on the marketing and sale of our products.

We have  entered  into a five-year  agreement  that  expires  October  2006 with
Imagenetix,  Inc., a company located in southern  California,  to supply us with
their  proprietary  products.  They have  experience  in packaging and supplying
health and  nutritional  products.  They will assist us in choosing a few select
products of theirs that they believe are their highest  quality  products,  with
large  potential  markets,  and with  profit  margins  that  would  warrant  our
attention.

We selected  Imagenetix,  Inc. because they are established in the nutrition and
natural health product area. If we were to lose this agreement with  Imagenetix,
Inc., our ability to obtain a supply of quality product on favorable terms would
probably  be greatly  hampered.  We believe  that we would be able to find other
suppliers,  but that they would require a greater expenditure of management time
and that profit margins on sales may decrease.

Our  websites  currently  list  two  products  for  sale.  Each  is  a  form  of
Imagenetix's  proprietary  product,  Celadrin(R).  We  market  a  cream  form of
Celadrin(R)in  a jar and an oral capsules  form of this product in a bottle.  We
place a label on each product  sold  identifying  the product as either  Vibrant
Creme or Vibrant  Celcaps.  We have no exclusivity  with respect to any of these
products.  In fact,  there are several  distributors  that market other  private
label forms of these products through their marketing  organizations.  It is our
understanding  that we are  the  first  E-commerce  company  to be  distributing
Celadrin(R).

Celadrin(R)is a scientifically  tested  formulated  product developed to provide
support  for healthy  joint  function  and  mobility.  Celadrin(R)consists  of a
complex  of  scientifically  targeted  fatty  acid  esters.  The  oral  form  of
Celadrin(R)was  subjected to clinical studies. The results of one of the studies
were  published  in the August,  2002 issue of The Journal of  Rheumatology.  We
intend to  capitalize  on what we  believe  will be a surge of demand  for these
products as new information is released on Celadrin(R)in the near future.

We are supplying products under our own Vibrant Health brand name. Imbedding the
Vibrant Health name as part of the product title may significantly  increase the
name  recognition of both the product and the Company and assist the customer to
associate it with quality and value.  Costs  associated  with labeling  products
with our name are  minimal  and  consist of  printing  new  labels  for  product
containers.

Three Month periods Ended September 30, 2003 and 2002

The Company had $6,800 in sales for the three month period ended  September  30,
2003 and sales of $15,791 for the same  three-month  period in 2002.  Sales were
lower in the quarter  ended  September  30, 2003 because in the third quarter of
2002 there had been a news  announcement  regarding the  Company's  product that
generated an increased  level of sales  activity.  Cost of goods sold was $1,933
for the  three-month  period ended September 30, 2003 compared to $5,215 for the
same  period in 2002.  The  Company  had a gross  profit of $4,867 for the three
months ended September 30, 2003 compared to $10,576 for the same period in 2002.

Operating  expenses  for the three month period  ended  September  30, 2003 were
$10,143 compared to $20,762 for the same period in 2002.  Expenses  consisted of
general corporate  administration,  legal and professional expenses,  accounting
and auditing costs and wages.  Decreased expenses for the period ended September
30,  2003 were  primarily  due to reduced  professional  fees since the  Company
completed an SB-2 offering in 2002. The Company has no interest  expense for the
three months ended  September  30, 2003  compared to $842 for the same period in
2002 because the Company paid off all of its long-term debt in 2002.

As a result of the foregoing factors,  the Company realized a net loss of $5,222
for the three months ended September 30, 2003 as compared to net loss of $11,028
for the same period in 2002.

Nine Month periods Ended September 30, 2003 and 2002

Sales were essentially level for the nine-month  comparative  periods at $19,794
for the nine month  period  ended  September  30,  2003 and $19,604 for the same
nine-month  period in 2002.  Cost of goods sold was  $5,791  for the  nine-month
period ended  September 30, 2003 compared to $6,575 for the same period in 2002.
The Company had a gross  profit of $14,003 for the nine months  ended  September
30, 2003 compared to $13,029 for the same period in 2002.

Operating  expenses  for the  nine-month  period ended  September  30, 2003 were
$42,132  compared  to $38,903 for the same  period in 2002,  essentially  level.
Expenses consisted of general corporate  administration,  legal and professional
expenses,  and  accounting  and  auditing  costs and wages.  The  Company has no
interest expense for the nine months ended September 30, 2003 compared to $3,642
for the same period in 2002  because the Company  paid off all of its  long-term
debt in 2002.

As a result of the foregoing factors, the Company realized a net loss of $27,882
for the nine months ended  September 30, 2003 as compared to net loss of $31,725
for the same period in 2002.

Liquidity and Capital Resources

At September 30, 2003,  the Company had assets  consisting of $23,307 of cash on
hand. Current liabilities  consisted of accounts payable and accrued expenses of
$4,052. The Company does not have any long-term capital commitments.

The Company  believes  that its  current  cash needs can be met with the cash on
hand and  from the  remaining  proceeds  of its  initial  public  offering.  The
offering closed in October 2002 and generated proceeds of $106,400. All of these
proceeds have been expended as of September 30, 2003. Should the Company find it
necessary to raise additional capital,  the Company may sell common stock of the
Company or enter into debt financing agreements.


Item 3. Controls and Procedures

The Company, under the supervision of the chief executive and financial officer,
has conducted an evaluation of the  effectiveness of the design and operation of
the Company's  disclosure  controls and procedures  within 90 days of the filing
date of this quarterly  report.  Based upon the results of this evaluation,  the
Company believes that they maintain proper  procedures for gathering,  analyzing
and  disclosing  all  information  in a timely  fashion  that are required to be
disclosed in its Exchange Act reports. There have been no significant changes in
the Company's controls subsequent to the evaluation date.


Part II: OTHER INFORMATION

Item 1. Legal Proceedings

The  Company is not a party  defendant  in any  material  pending or  threatened
litigation  and to its  knowledge,  no  action,  suit or  proceedings  has  been
threatened against its officers and its directors.


Item 2.  Changes in Securities and Use of Proceeds

On July 9, 2001, we issued a total of 2,959,000 common shares to our founder and
President,  Thomas  H.  McAdam  in  connection  with  beginning  operations  and
acquiring our subsidiary. The shares were issued as follows: 100,000 shares were
issued  in  exchange  for  $1,000  cash.  2,109,000  shares  of  Vibrant  Health
International  common  stock were issued and  exchanged  for  703,000  shares of
Vibrant Health, Inc. common stock.  750,000 shares were issued,  valued at $750,
in  consideration  of  receiving a $15,000  loan.  The  securities  were sold in
private transactions, without registration in reliance on the exemption provided
by Section 4(2) of the  Securities  Act. The investor had access to all material
information pertaining to the Company and its financial condition.  The investor
completed and signed a subscription agreement attesting to his sophistication or
accredited  investor status and investment intent. No broker was involved and no
commissions were paid in the transactions.

Also on July 9, 2001, we issued  801,000  shares valued at $801 to a shareholder
in exchange for 267,000 shares of Vibrant Health,  Inc. The securities were sold
in a private  transaction,  without  registration  in reliance on the  exemption
provided by Section 4(2) of the  Securities  Act. The investor had access to all
material  information  pertaining to the Company and its financial condition and
the investor  completed  and signed a  subscription  agreement  attesting to his
sophistication  or accredited  investor status and investment  intent. No broker
was involved and no commissions were paid in the transactions.

On August 27,  2001,  Mr.  McAdam  purchased  550,000  shares of Vibrant  Health
International common stock from a shareholder for $550 in a private transaction,
bringing Mr. McAdam's total ownership to 3,509,000  shares, or approximately 80%
of our total issued and outstanding common stock.

In September  2001, we issued  175,000  shares of common stock to two accredited
investors  for  a  total  of  $5,250.   The  securities  were  sold  in  private
transactions,  without  registration  in reliance on the  exemption  provided by
Section 4(2) of the  Securities  Act.  Each  investor had access to all material
information pertaining to the Company and its financial condition. Each investor
completed and signed a subscription agreement attesting to his sophistication or
accredited  investor status and investment intent. No broker was involved and no
commissions were paid in the transactions.

The  Company  filed  an SB-2  Registration  Statement  with the  Securities  and
Exchange  Commission  offering  a minimum  of  350,000  shares  and a maximum of
800,000 shares at $0.25 per share.  The offering  became  effective on August 2,
2002 and closed on October 22,  2002.  The Company  successfully  completed  the
offering  of 425,600  shares of common  stock to 44  shareholders  and  received
proceeds  of  $106,400.   The  Company  incurred   expenses  in  the  amount  of
approximately $25,000 relating to the Registration Statement.  Expenses included
legal fees,  accounting fees,  escrow fees,  filing fees,  printing and transfer
agent costs.  The Company also repaid loans of $40,000 together with interest of
$3,998. There were no underwriters'  discounts,  commissions or finders' fees. A
table  detailing  the use of  proceeds  through  September  30, 2003 is provided
below.


Use of Proceeds                                             Amount

Debt Repayment                                             $40,000
Interest on Loans                                           $3,998
Legal Fees                                                 $10,857
Accounting and Professional Fees                           $18,180
Wages                                                      $17,500
Website and Marketing                                       $5,757
Various working capital items                              $10,108

Total Proceeds Expended                                  $ 106,400

Balance of Proceeds Remaining                                $   0



Item 6. Exhibits and Reports on Form 8-K

Reports on Form 8-K:

No reports on Form 8-K were filed by  Vibrant  Health  International  during the
three months ended September 30, 2003.

Exhibits:

Exhibit         Title                                                Location
Number

31              Certification of the Chief Executive Officer and     Attached
                Chief Financial Officer pursuant to 18 U.S.C.
                Section 1350, as adopted pursuant to Section 302 of
                the Sarbanes-Oxley Act of 2002

32              Certification of the Chief Executive Officer and     Attached
                Chief Financial Officer pursuant to 18 U.S.C.
                Section 1350, as adopted pursuant to Section 906 of
                the Sarbanes-Oxley Act of 2002


                                   SIGNATURES


Pursuant to the  requirements of the Securities  Exchange Act of 1934, this Form
10-QSB Report,  for the Quarter ended  September 30, 2003, has been signed below
by the following  person on behalf of the  Registrant and in the capacity and on
the date indicated.



                                          VIBRANT HEALTH INTERNATIONAL

October 30, 2003                                By  /s/Thomas H. McAdam
                                                Thomas H. McAdam
                                                Chief Executive Officer and
                                                Chief Financial Officer`